What is the recommended dose and frequency of ceftriaxone (Ceftriaxone) administration?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ceftriaxone Dosing and Frequency

For most adult infections, administer ceftriaxone 1-2 grams once daily IV or IM, but for serious CNS infections including meningitis, you must use 2 grams every 12 hours to ensure adequate CSF concentrations throughout the dosing interval. 1, 2

Standard Adult Dosing by Infection Type

Uncomplicated Infections

  • Uncomplicated gonococcal infections: 250 mg IM as a single dose 1, 2
  • Skin and soft tissue infections: 1 gram every 12-24 hours depending on severity 1
  • Urinary tract infections: 1 gram IM/IV every 24 hours initially, then consider oral therapy 1

Serious Infections Requiring Higher Dosing

  • Bacterial meningitis: 2 grams IV every 12 hours (total 4 grams daily) for 10-14 days 1, 2
  • Disseminated gonococcal infection: 1 gram IM/IV every 24 hours, continue for 24-48 hours after improvement, then switch to oral therapy to complete one week 1
  • Gonococcal meningitis/endocarditis: 1-2 grams IV every 12 hours for 10-14 days (meningitis) or at least 4 weeks (endocarditis) 1
  • HACEK endocarditis: 2 grams per 24 hours IV/IM in 1 dose for 4 weeks (6 weeks for prosthetic valve) 1

Pathogen-Specific Meningitis Dosing

  • Pneumococcal meningitis: 2 grams IV every 12 hours for 10-14 days, extend if patient not recovered by day 10 1
  • Meningococcal meningitis: 2 grams IV every 12 hours for 5 days 1
  • Haemophilus influenzae meningitis: 2 grams IV every 12 hours for 10 days 1
  • Enterobacteriaceae CNS infections: 2 grams IV every 12 hours for 21 days 1

Pediatric Dosing

Neonates (≤28 days)

  • Standard infections: 50 mg/kg once daily IV/IM 1, 2
  • Meningitis: 100 mg/kg once daily (not to exceed 4 grams) 2
  • Critical warning: Contraindicated in neonates requiring calcium-containing IV solutions due to precipitation risk 2
  • Administration: Infuse over 60 minutes in neonates to reduce bilirubin encephalopathy risk 2

Infants and Children

  • Skin/soft tissue infections: 50-75 mg/kg once daily (max 2 grams) 2
  • Acute otitis media: 50 mg/kg IM single dose (max 1 gram) 2
  • Serious infections (non-meningitis): 50-75 mg/kg divided every 12 hours (max 2 grams daily) 2
  • Meningitis: 100 mg/kg/day (max 4 grams daily), can be given once daily or divided every 12 hours 2
  • Gonococcal infections in children <45 kg: 125 mg IM single dose for uncomplicated; 50 mg/kg daily (max 1 gram) for 7 days for bacteremia/arthritis, 10-14 days for meningitis 1

Critical Dosing Considerations

When Twice-Daily Dosing is Mandatory

The long half-life of ceftriaxone allows once-daily dosing for most infections, but CNS infections are the critical exception. 3 Twice-daily dosing (every 12 hours) is absolutely required for:

  • All bacterial meningitis cases during at least the first 24 hours to achieve rapid CSF sterilization 1
  • Infections with high MICs or resistant strains 3
  • Vertebral discitis with epidural involvement 1

Special Population Adjustments

  • Elderly patients (≥60 years with meningitis): Add amoxicillin 2 grams IV every 4 hours to ceftriaxone 2 grams every 12 hours to cover Listeria monocytogenes 1
  • Penicillin-resistant pneumococci: Add vancomycin 15-20 mg/kg IV twice daily (target trough 15-20 mg/mL) or rifampin 600 mg twice daily to ceftriaxone regimen 1
  • Renal/hepatic impairment: No dosage adjustment necessary unless both severe renal and hepatic impairment present 2

Resistant Organisms

For pharyngeal gonorrhea with elevated MICs, treatment failures occur with standard 250-500 mg doses; consider twice-daily dosing of 2 grams to achieve free plasma concentration of 2-3 mg/L at 24 hours 1

Administration Guidelines

Intramuscular Administration

  • Inject well within the body of a relatively large muscle 2
  • Aspirate to avoid unintentional vascular injection 2
  • Reconstitute to 250 mg/mL or 350 mg/mL concentration 2

Intravenous Administration

  • Infuse over 30 minutes for adults 2
  • Infuse over 60 minutes for neonates to reduce bilirubin encephalopathy risk 2
  • Use concentrations between 10-40 mg/mL 2
  • Never mix with calcium-containing solutions (Ringer's, Hartmann's) due to precipitation risk 2

Common Pitfalls to Avoid

  1. Using once-daily dosing for meningitis: This is inadequate for CNS penetration; always use every 12-hour dosing for meningitis 1, 3
  2. Forgetting to add antichlamydial coverage: When treating gonococcal infections, add appropriate coverage if Chlamydia trachomatis not ruled out 1, 2
  3. Underdosing pharyngeal gonorrhea: Standard 250 mg doses have documented failures; use higher doses for pharyngeal infections 1
  4. Administering to hyperbilirubinemic neonates: Ceftriaxone displaces bilirubin from albumin binding sites 2
  5. Mixing with calcium-containing solutions: Can cause fatal precipitation 2

Maximum Dosing Limits

  • Adults: Do not exceed 4 grams daily 2
  • Pediatrics: Do not exceed adult dosing even when weight-based calculations suggest higher doses 4, 2

References

Guideline

Ceftriaxone Dosing Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Ceftriaxone Pharmacokinetics

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.